| abstract |
the present invention relates to pharmaceutical compositions comprising (e) -4- (2- (aminomethyl) -3-fluoroalyloxy) -n-tert-butylbenzamide with the following chemical structure or a pharmaceutically acceptable salt thereof as an active pharmaceutical ingredient, particularly pharmaceutical compositions comprising (e) -4- (2- (aminomethyl) -3-fluoroalyloxy) -n-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, their preparation, their use and methods for therapeutic treatment. |